CD34 and neoplasm: In the non-tumour control cells (CD34+HSC and CD133+HSC), all polyphenols were shown to reduce the toxicity of topoisomerase II inhibitors on ATP levels and caspase 3 activity, suggesting polyphenols could be protective in normal cells, and hence could reduce off-target effects.